For example, for breast cancer, we collect the status of standard biomarkers, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) receptor and BRCA mutation status, when available. This evidence concerns the gene ESR1 and breast cancer.